Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $108M | $167M | -35.33% |
Cost of Revenue | $90M | $96M | -6.25% |
Operating Income | $-1.05B | $-1.27B | +17.06% |
Net Income | $-971M | $-1.18B | +17.36% |
EPS (Basic) | $-2.52 | $-3.07 | +17.92% |
EPS (Diluted) | $-2.52 | $-3.07 | +17.92% |
R&D Expense | $856M | $1.06B | -19.47% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $12.7B | $16.73B | -24.06% |
Current Assets | $6.77B | $9.6B | -29.52% |
Total Liabilities | $2.64B | $3.91B | -32.57% |
Current Liabilities | $1.6B | $2.38B | -32.61% |
Stockholders' Equity | $10.07B | $12.82B | -21.46% |
Cash & Equivalents | $1.62B | $2.05B | -20.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-1.04B | $-989M | -4.85% |
Investing Cash Flow | $730M | $118M | +518.64% |
Financing Cash Flow | $4M | $14M | -71.43% |
D&A | $38M | $35M | +8.57% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -972.2% | -758.1% | -214.14% |
Net Margin | -899.1% | — | — |
ROE | -9.6% | — | — |
ROA | -7.6% | — | — |
Current Ratio | $4.218 | — | — |
Debt to Equity | $0.262 | — | — |
Other companies in Biotechnology